![\"\"](\"http:\/\/www.revistahcsm.coc.fiocruz.br\/english\/wp-content\/uploads\/2021\/01\/TeQueremosVacunadoBolivia.jpg\")
<\/a>Cartel de la campa\u00f1a de vacunaci\u00f3n del Ministerio de Previsio\u0301n Social y Salud Pu\u0301blica de Bolivia. Fuente: US National Library of Medicine.<\/p><\/div>\n
Seven months ago, the Pan-American Health Organization confirmed that Latin America and the Caribbean had\u00a0become the global epicenter for COVID-19<\/a>. According to PAHO data<\/a>, on January 17th the region had\u00a017,421,914 cases, with\u00a0550,775 deaths, an increase, respectively, of\u00a0 5.1%\u00a0 and 3.7% from January 10th.<\/p>\n However, immunization has already begun in countries such as Mexico, Chile, Costa Rica, Argentina and Brazil.<\/p>\n In Brazil, two vaccines were recently approved by the Brazilian Health Regulatory Agency (Anvisa). One of them started to be negotiated\u00a0in late June 2020, when the Oswaldo Cruz Foundation (Fiocruz) bought the vaccine developed by the University of Oxford with AstraZeneca, a giant pharmaceutical company in the UK, as part of a technology transfer agreement in order to produce it locally. The second vaccine approved was\u00a0developed by the Butantan Institute, in S\u00e3o Paulo, together with Inovac Biotech, a private Chinese company.<\/p>\n In its 25 years of existence, HCS-Manguinhos have published several articles on vaccines, vaccination campaigns and disease eradication in Latin America.\u00a0Among the topics covered we can mention the vaccination campaigns and public policies that eradicated polio and smallpox, research for the development of a vaccine against malaria and the international circulation of knowledge that favored the development of vaccines in Brazil.<\/p>\n The\u00a0international disputes surrounding antiplague serums and vaccines is discussed in the article\u00a0\u00a0The establishment of the Manguinhos laboratory, 1894-1902<\/a>.\u00a0 Matheus Alves da Silva analyzes\u00a0\u00a0the 1900 establishment of the Federal Serum Therapy Institute of Manguinhos, Fiocruz, in Rio de Janeiro, focusing on the international circulation of knowledge.<\/p>\n Instituto Soroter\u00e1pico Federal [Federal Serum Therapy Institute], Manguinhos, Fiocruz, Rio de Janeiro, around 1900. Source: Brasiliana Fotogr\u00e1fica<\/p><\/div>In 1967 the World Health Organization (WHO)\u00a0launched the\u00a0global smallpox eradication programme and in 1980 proclaimed the eradication of this disease.<\/span> The\u00a0article\u00a0Control, containment and health education in the smallpox-vaccination campaigns in Mexico in the 1940s<\/a>, by\u00a0Claudia Agostoni, analyzes why a uniform and coordinated vaccination method was adopted to counter the outbreaks of this endemic disease, especially in central Mexico and the reasons why smallpox vaccination was considered critical to establish a culture of prevention.<\/span><\/p>\n In\u00a0Smallpox eradication, laboratory visits, and a touch of tourism: travel notes of a Canadian scientist in Brazil<\/a>, Steven Palmer, Gilberto Hochman, and Danieli Arbex present the travel notes diary of Canadian scientist Robert J. Wilson when he visited Brazil in April 1967 during the Smallpox Eradication Programme run by the WHO.\u00a0Wilson\u2019s report makes it possible to reflect on the smallpox eradication campaign in Brazil and on the Canada-Brazil cooperation to improve the quality of the smallpox vaccine.<\/p>\n \u201cFila de gente en la calle entrando a un edificio del Departamento de Salubridad P\u00fablica, Oficina de Vacunaci\u00f3n \u2018Dr. Balmis\u2019 en la ciudad de M\u00e9xico\u201d. Fuente: Agostoni, Claudia. “M\u00e9dicos, campa\u00f1as y vacunas la viruela y la cultura de su prevenci\u00f3n en M\u00e9xico 1870-1952<\/a>“.<\/p><\/div>\n In\u00a0A battle won: the elimination of poliomyelitis in Cuba<\/a>\u00a0Enrique Beldarra\u00edn Chaple, professor at the Medical University of La Habana, discusses the central role of the state in the elimination of polio in the country and aims to reconstruct the history of the disease in Cuba until the first National Campaign of Vaccination Antipolio (1962<\/span> ) and it also analyzes\u00a0\u00a0the continuity of the annual vaccination campaigns has the certification of their elimination (1994).<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n Breakthroughs towards a malaria vaccine<\/a>\u00a0is a testimony by\u00a0scientist\u00a0Ruth Nussenzweig, C.V. Starr Professor at New York University School of Medicine about her work to develop\u00a0 an antimalarial vaccine. In her testimony, she traces some of the stages through which her research has passed.<\/p>\n The\u00a0disputed race for the vaccine against the new coronavirus <\/a>is the topic explored by Marcos Cueto, scientific editor of HCS-Manguinhos, in the Editor\u2019s note of HCSM recent\u00a0issue. According to Cueto, this race reveals the importance of technology in the battle against the pandemic, but a look at past epidemic outbreaks have shown that the fight against diseases needs to consider social and institutional\u00a0factors.<\/p>\n See all articles stories and about vaccination already published in HCSM:<\/p>\n<\/div>\n The\u00a0 Politics of Vaccination<\/a>\u00a0– The article about the yellow fever vaccine in Brazil was written by Jaime Benchimol, member of our scientific editorial council.<\/p>\n Julie Laplante; Julie Bruneau,\u00a0<\/b>Aper\u00e7u d’une anthropologie du vaccin:\u00a0regards sur l’\u00e9thique d’une pratique humanitaire<\/a>.\u00a0Hist. cienc. saude-Manguinhos<\/i>\u00a0[online]. 2003, vol.10, suppl.2.<\/p>\n Las campa\u00f1as de vacunaci\u00f3n contra la viruela en M\u00e9xico durante la d\u00e9cada de 1940<\/a>\u00a0El art\u00edculo examina algunas transformaciones por las que atravesaron los programas mexicanos de vacunaci\u00f3n al establecerse la Campa\u00f1a Nacional contra la Viruela.<\/p>\n El devenir hist\u00f3rico de la poliomielitis en la Argentina<\/a>\u00a0Rese\u00f1a de Fausto Gabriel Ferreyra sobre la investigaci\u00f3n hist\u00f3rica de Daniela Testa acerca de la poliomielitis en Argentina.<\/p>\n Aguirre-Bola\u00f1os, Nydia. La etapa posterior a la erradicaci\u00f3n de la viruela en M\u00e9xico, 1952-1977<\/a>. Hist. cienc. saude-Manguinhos, Set 2018, vol.25, no.3.<\/p>\n Chaple, Enrique Beldarra\u00edn.\u00a0Una batalla ganada: la eliminaci\u00f3n de la poliomielitis en Cuba<\/span><\/a>.\u00a0Hist. cienc. saude-Manguinhos<\/i>, Set 2015, vol.22, no.3<\/p>\n Altink, Henrice. The black scourge? Race and the Rockefeller Foundation\u2019s tuberculosis commission in interwar Jamaica<\/a>. Hist. cienc. saude-Manguinhos, Oct 2017, vol.24, no.4.<\/p>\n Nussenzweig, Ruth Sonntag. Breakthroughs towards a malaria vaccine<\/a>. Hist. cienc. saude-Manguinhos, June 2011, vol.18, no.2<\/p>\n Palmer, Steven, Hochman, Gilberto and Arbex, Danieli. Smallpox eradication, laboratory visits, and a touch of tourism: travel notes of a Canadian scientist in Brazil<\/a>. Hist. cienc. saude-Manguinhos, 2010, vol.17, no.3.<\/p>\n Hochman, Gilberto and Palmer, Steven\u00a0Smallpox eradication and Brazil:\u00a0an interview with Donald A. Henderson<\/span><\/a>.\u00a0Hist. cienc. saude-Manguinhos<\/i>, 2010, vol.17, no.3.<\/p>\n![\"\"](\"http:\/\/www.revistahcsm.coc.fiocruz.br\/english\/wp-content\/uploads\/2018\/12\/laboratorio-manguinhos.jpg\")
<\/a>![\"\"](\"http:\/\/www.revistahcsm.coc.fiocruz.br\/english\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-19-at-8.33.28-AM.png\")
<\/a>